Howard M Fillit, MD
img_Howard M Fillit
CLINICAL PROFESSOR | Geriatrics and Palliative Medicine
CLINICAL PROFESSOR | Medicine
CLINICAL PROFESSOR | Neuroscience
Are you a patient?
Specialties
Internal Medicine, Geriatrics, Palliative Care

BA, Cornell University

MD, SUNY Upstate Medical University College of Medicine

Residency, Internal Medicine, Beth Israel Medical Center-Petrie Division

Fellowship, Nephrology, Hospital for Special Surgery

Certifications

American Board of Internal Medicine
Publications

Selected Publications

Implementing early detection of cognitive impairment in primary care to improve care for older adults. Nicole R. Fowler, Katherine A. Partrick, James Taylor, Michael Hornbecker, Kevin Kelleher, Malaz Boustani, Jeffrey L. Cummings, Tim MacLeod, Michelle M. Mielke, Jared R. Brosch, Janice Lee, Eli Shobin, James E. Galvin, Howard Fillit, Chinedu Udeh-Momoh, Deanna R. Willis. Journal of Internal Medicine

Local molecular and connectomic contributions of tau-related neurodegeneration. Fardin Nabizadeh, Ansgar J. Furst, Joy L. Taylor, Jerome A. Yesavage, Gail Li, Eric C. Petrie, Elaine R. Peskind, Sandra Harding, JJay Fruehling, Dino Massoglia, Olga James, Konstantinos Arfanakis, Debra Fleischman, Karl Friedl, Shannon Finley, Jacqueline Hayes, Rosemary Morrison, Melissa Davis, Jordan Grafman, Thomas Neylan, Balebail Ashok Raj, Kristin Fargher, Amanda Smith, Lisa Raudin, Gloria Chaing, Norman Relkin, Karen Elizabeth Smith, Hyungsub Shim, Laura L.Boles Ponto, Susan K. Schultz, Antero Sarrael, Raymundo Hernando, Nunzio Pomara, Dick Drost, Irina Rachinsky, Stephen Pasternak, David Bachman, Kenneth Spicer, Jacobo Mintzer, Bruce L. Miller, Howard J. Rosen, Stephen Correia, Paul Malloy, Stephen Salloway, Geoffrey Tremont, Henry Querfurth, Brian R. Ott, Franklin Watkins, Hillel Grossman, Howard Fillit. GeroScience

Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation. Jeffrey Cummings, Michael Gold, Mark Mintun, Michael Irizarry, Andrew von Eschenbach, Suzanne Hendrix, Donald Berry, Cristina Sampaio, Kaycee Sink, Jaren Landen, Miia Kivipelto, Michael Grundman, Steven E. Arnold, Allan Green, Katherine Partrick, Laura Nisenbaum, Aaron Burstein, Howard Fillit. The journal of prevention of Alzheimer's disease

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Fillit during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Alector
  • LifeWorx
  • Eli Lilly and Company

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.